38
Views
4
CrossRef citations to date
0
Altmetric
Miscellaneous

Antidepressant therapy: new targets for drug development

Pages 1693-1711 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Harry R Howard. (2007) 4-Arylpiperidine derivatives and uses thereof for preparing a medicament for the treatment of CNS disorders. Expert Opinion on Therapeutic Patents 17:2, pages 251-253.
Read now

Articles from other publishers (3)

Gabriella De Martino, Giuseppe La Regina, Francesco La Torre, Roberto Cirilli, Ilario Mereghetti, Alfredo Cagnotto, Marino Artico & Romano Silvestri. (2005) Chiral resolution and binding study of 1,3,4,14b-tetrahydro-2,10-dimethyl-2H,10H-pyrazino[2,1-d]pyrrolo[1,2-b] [1,2,5]benzotriazepine (10-methyl-10-azaaptazepine) and 2-methyl-1,3,4,14b-tetrahydro-2H-pyrazino[2,1-d]pyrrolo[1,2-b] [1,2,5]benzothiadiazepine 10,10-dioxide (tiaaptazepine). Il Farmaco 60:11-12, pages 931-937.
Crossref
Anne Wijkhuisen, Sylvie Tymciu, Jacqueline Fischer, Coralie Alexandrenne, Christophe Créminon, Yveline Frobert, Jacques Grassi, Didier Boquet, Marie Conrath & Jean-Yves Couraud. (2003) Pharmacological properties of peptides derived from an antibody against the tachykinin NK1 receptor for the neuropeptide substance P. European Journal of Pharmacology 468:3, pages 175-182.
Crossref
. (2002) Current Awareness. Human Psychopharmacology: Clinical and Experimental 17:2, pages 123-130.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.